Pelage Pharmaceuticals' PP405 aims to treat hairloss by reactivating dormant hair follicle stem cells, showing promising results in early trials. The company plans to present their findings at the American Academy of Dermatology Annual Meeting in 2026.
PP405 shows promise in regenerating hair by activating dormant follicles. Other treatments like VDPHL01 and Breezula are also advancing, providing new hope for hairloss solutions.
The conversation discusses how Tretinoin may improve the effectiveness of Minoxidil for treating hairloss by increasing the activity of certain enzymes in hair follicles. One user comments that this information is not new.
Longitudinal partial follicular unit transplantation involves extracting part of the donor follicular unit, allowing the donor area to be overharvested without noticeable hairloss. The conversation questions if this method is practiced in clinics or if it's theoretical, and whether it relates to hair cloning or multiplication.